Hydroxychloroquin (HCQ) in Pediatric Interstitial Lung Disease (ILD)
Status:
Suspended
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This is an exploratory Phase 2a, randomized, double-blind, placebo-controlled,
parallel-group, multinational study investigating the initiation or withdrawal of
hydroxychloroquine in subjects with chILD.